Switch theme
Sign up to access all valuation multiples
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
1870
53K+
LTM Revenue $19.9B
LTM EBITDA $3.6B
$39.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
GE HealthCare has a last 12-month revenue (LTM) of $19.9B and a last 12-month EBITDA of $3.6B.
In the most recent fiscal year, GE HealthCare achieved revenue of $19.7B and an EBITDA of $3.7B.
GE HealthCare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See GE HealthCare valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $19.9B | XXX | $19.7B | XXX | XXX | XXX |
| Gross Profit | $8.3B | XXX | $8.2B | XXX | XXX | XXX |
| Gross Margin | 41% | XXX | 42% | XXX | XXX | XXX |
| EBITDA | $3.6B | XXX | $3.7B | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 19% | XXX | XXX | XXX |
| EBIT | $3.1B | XXX | $2.6B | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $1.9B | XXX | $2.0B | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $6.1B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, GE HealthCare's stock price is $71.
GE HealthCare has current market cap of $32.3B, and EV of $39.0B.
See GE HealthCare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $39.0B | $32.3B | XXX | XXX | XXX | XXX | $4.30 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, GE HealthCare has market cap of $32.3B and EV of $39.0B.
GE HealthCare's trades at 2.0x EV/Revenue multiple, and 10.6x EV/EBITDA.
Equity research analysts estimate GE HealthCare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
GE HealthCare has a P/E ratio of 16.6x.
See valuation multiples for GE HealthCare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $32.3B | XXX | $32.3B | XXX | XXX | XXX |
| EV (current) | $39.0B | XXX | $39.0B | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 10.9x | XXX | 10.6x | XXX | XXX | XXX |
| EV/EBIT | 12.7x | XXX | 14.9x | XXX | XXX | XXX |
| EV/Gross Profit | 4.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 16.6x | XXX | 16.2x | XXX | XXX | XXX |
| EV/FCF | 27.1x | XXX | 25.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialGE HealthCare's last 12 month revenue growth is 4%
GE HealthCare's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
GE HealthCare's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
GE HealthCare's rule of X is 28% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for GE HealthCare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 0% | XXX | -1% | XXX | XXX | XXX |
| Rule of 40 | 22% | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 28% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
GE HealthCare acquired XXX companies to date.
Last acquisition by GE HealthCare was XXXXXXXX, XXXXX XXXXX XXXXXX . GE HealthCare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was GE HealthCare founded? | GE HealthCare was founded in 1870. |
| Where is GE HealthCare headquartered? | GE HealthCare is headquartered in United States of America. |
| How many employees does GE HealthCare have? | As of today, GE HealthCare has 53K+ employees. |
| Who is the CEO of GE HealthCare? | GE HealthCare's CEO is Mr. Peter J. Arduini. |
| Is GE HealthCare publicy listed? | Yes, GE HealthCare is a public company listed on NAS. |
| What is the stock symbol of GE HealthCare? | GE HealthCare trades under GEHC ticker. |
| When did GE HealthCare go public? | GE HealthCare went public in 2022. |
| Who are competitors of GE HealthCare? | Similar companies to GE HealthCare include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of GE HealthCare? | GE HealthCare's current market cap is $32.3B |
| What is the current revenue of GE HealthCare? | GE HealthCare's last 12 months revenue is $19.9B. |
| What is the current revenue growth of GE HealthCare? | GE HealthCare revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of GE HealthCare? | Current revenue multiple of GE HealthCare is 2.0x. |
| Is GE HealthCare profitable? | Yes, GE HealthCare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of GE HealthCare? | GE HealthCare's last 12 months EBITDA is $3.6B. |
| What is GE HealthCare's EBITDA margin? | GE HealthCare's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of GE HealthCare? | Current EBITDA multiple of GE HealthCare is 10.9x. |
| What is the current FCF of GE HealthCare? | GE HealthCare's last 12 months FCF is $1.4B. |
| What is GE HealthCare's FCF margin? | GE HealthCare's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of GE HealthCare? | Current FCF multiple of GE HealthCare is 27.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
